Navigation Links
New FDA approved pre-surgical treatment for cleft lip/palate

OTTAWA, Dec. 12, 2013 /PRNewswire/ -- Parents and healthcare professionals who care for more than 4,000 cleft lip/palate babies born each year in the U.S. now have a new non-invasive pre-surgical treatment available that research finds is as effective as the established method, yet significantly less expensive.

The DynaCleft® cleft lip and palate treatment device uses an elastomeric band to bridge the cleft segments. Its elastic core applies controlled forces to both lip and palate, while gently conforming to the baby's mouth to accommodate feeding, crying or smiling. Applied topically shortly after birth, the device slowly guides soft tissues and bone of the cleft lip and palate into a better position for repair, making first cleft surgery easier for both surgeon and baby.

Developed in collaboration with cleft teams, DynaCleft® saves time, money and most importantly, provides greater comfort for the baby. Used together with a simple nasal elevator hand-fashioned from common clinical materials, the new method makes pre-surgical cleft lip and palate treatment accessible to more newborns and greatly reduces the burden of care for parents.

A study published recently in The Cleft Palate-Craniofacial Journal found the clinical effectiveness of this new topical pre-surgical treatment equal to that of the orthodontic appliance widely considered to be the gold standard of pre-surgical treatment for cleft lip and palate. The randomized, prospective study of babies born between 2007 and 2010 with complete unilateral cleft lip and palate compared the results of cleft width reduction and nasal deformity correction between the NAM-Grayson appliance and the new topical method, and concluded that the combination of DynaCleft® with a nasal elevator achieves equivalent results to the NAM (nasoalveolar molding) intra-oral appliance.

Dr. LaQuia Walker, a pediatric dentist with the Riley Hospital for Children at IU Health's Craniofacial Anomalies Team in Indianapolis, says her team uses the DynaCleft® plus nasal elevator method in their protocol because they believe the burden of care on parents of cleft babies is too high with the NAM method. The NAM requires continuous adjustments over a three-to-six month period, so parents must commit to bringing their baby in weekly for custom shaping of the appliance by a specially-trained orthodontist. The time and out-of-pocket expenses required simply to attend appointments can be prohibitive for many families.

"Although NAM therapy is considered to be one of the most effective forms of pre-surgical orthopedics, it is also one of the most costly and time-consuming," says Dr. Walker. "NAM is a labor-intensive technique that requires frequent visits to our craniofacial center over several months. Such requirements can be problematic for many parents who commonly travel great distances as well as having other responsibilities that cannot be put on hold during these first crucial months of the infant's life."

According to the study's lead author Dr. Luis Monasterio, a specialist with more than 40 years experience treating cleft lip and palate babies, this new topical technique may also make babies happier. In the published study, he described the experience of wearing an intra-oral orthodontic appliance from a newborn baby's perspective: "If I was an infant with complete unilateral cleft lip and palate, and soon after my birth someone would place an appliance inside my mouth, a nasal antenna which would obstruct my nasal passage, and cover around my mouth with paper tape, I would certainly not be a happy baby."

The DynaCleft® device, developed by Canica Design Inc. in Ottawa, Ontario is the only FDA, EU and Health Canada-approved medical device designed specifically for the pre-surgical treatment of cleft lip and palate.

For more information (including "before and after" case photos and video) visit

SOURCE Canica Design Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Shire Announces that the US Food and Drug Administration has Responded to its Citizen Petition for Adderall XR and has Approved One Abbreviated New Drug Application for Generic Adderall XR
2. Statement from Mary Vogt, President of Home Access Health Corporation, manufacturer of the Home Access HIV-1 test system, the only over-the-counter HIV test previously approved by the FDA for at-home use.
3. Hologic Human Papillomavirus (HPV) High-Risk Test Approved for Use in The Netherlands Population Cervical Screening Programme
4. Life Technologies Acquires Pinpoint Genomics and CLIA-Approved Lung Cancer Test
5. Stem Cell Supplement Approved In Taiwan
6. InkSure Introduces FDA Approved High Security Taggants for Direct Food Contact
7. First FDA approved subcutaneous implantable defibrillator available for patients at risk for sudden cardiac arrest
8. Shares of Oramed Pharmaceuticals Are Approved for Listing on the Nasdaq Capital Market
9. Experienced Surgeon Vs. FDA-Approved Robot
10. SafeCode Drug Technologies to Hire Project Manager to Market FDA Approved Painless Injection Device
11. Roche/Chugais Bitopertin Will Garner Nearly $1.5 Billion in Major-Market Sales in 2022 as the First Approved Treatment for Negative Symptoms in Schizophrenia
Post Your Comments:
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Issue 52" report to their offering. ... treatment creates a favourable commercial environment for MedImmune to enter. ... base that will serve to drive considerable growth for effective ... serve to cap sales considerably, but development is still in ...
(Date:6/23/2016)... 2016 , , , WHEN: ... 2016 , , , , LOCATION: , , , Online, ... , , EXPERT PANELISTS:  , , , Frost & Sullivan,s Global ... Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager ... pharmaceutical industry is witnessing an exceptional era. Several new demand spaces, ...
(Date:6/23/2016)... the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in Bogota. Colombia ... ... Sandra ... ... Astellas is a pharmaceutical company ...
Breaking Medicine Technology:
(Date:6/25/2016)... Viejo, California (PRWEB) , ... June 25, 2016 , ... ... to fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... fully customizable and all within Final Cut Pro X . Simply select a ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be ...
Breaking Medicine News(10 mins):